Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test
Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences. www.marketwatch.com #Abbott…
Tag: Sciences
Abbott to Buy Cologuard Maker Exact Sciences for $21 Billion
Abbott Laboratories agreed to acquire cancer-screening company Exact Sciences Corp. in a deal with a total equity value of about…
Gilead Sciences, Inc. (GILD)’s Mixed Quarter Draws Divergent Analyst Views
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best blue-chip stocks to buy now. On November 3, Bernstein SocGen Group…
Anthropic’s Claude Life Sciences gives researchers an AI boost
Dario Amodei, Anthropic CEO, speaking on CNBC’s Squawk Box outside the World Economic Forum in Davos, Switzerland on Jan. 21st, 2025.…
Parsons Acquires Applied Sciences to Bolster Water Infrastructure Capabilities
Parsons Corporation (NYSE:PSN) is one of the best-performing midcap tech stocks in the last 3 years. On October 2, 2025,…
Leerink Partners Maintains Buy on Gilead Sciences (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the Most Undervalued S&P 500 Stocks to Buy Right Now. On September 2,…
‘Strong Need’ for Life Sciences Investing: Portal Innovations CEO
Venture firm Portal Innovations is raising a $100 million life sciences fund and helping universities launch startup incubators, as institutions…
Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears
Gilead Sciences (NASDAQ:GILD) announced its second-quarter 2025 earnings and revised annual outlook after the market closed on Thursday. The HIV…
180 Life Sciences Secures $425 Million to Build ETH Treasury
180 Life Sciences is pivoting to crypto with a $425 million private placement to build an ether treasury and rebrand…
180 Life Sciences bets $425m on Ethereum treasury in bid to become ETHZilla
Palo Alto’s 180 Life Sciences is making a radical pivot, ditching biotech for crypto. With a $425 million private placement…